Bayan Takizawa is a cofounder and Chief Strategy Officer at CONTINUUS Pharmaceuticals. Dr. Takizawa has helped the CONTINUUS team raise over $90 million through financing rounds, grants, and contracts with multiple commercial partners and government agencies.
Prior to joining CONTINUUS, Bayan was a consultant at The Chartis Group, an advisory firm that provides strategic and operational support for hospitals and healthcare systems. While with Chartis, Bayan helped create a business strategy to partner with a major health system and a premier academic medical center. He also led work streams to develop and support service formation, non-clinical performance improvement, and clinical performance improvement at several health systems. Prior to Chartis, Bayan worked at Actin Biomed, a healthcare investment firm, and Yale New Haven Hospital as a General Surgery and Urology resident.
Bayan has an MD from Yale, an MS in Engineering Systems, an MBA from MIT, and a BS in Chemical Engineering from Cornell. He has multiple publications in peer-reviewed journals and is an active member of the Massachusetts life sciences community.